Cipla Ltd. announced the acquisition of nutrition products portfolio from Wanbury Ltd.
The homegrown drugmaker acquired four brands—CPink, CDense, Productiv and Folinine—to strengthen its presence in women's health portfolio.
The nutraceutical products to be sold under the four umbrella brands would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies, Cipla said in a regulatory filing. This includes supplements such as multivitamins, multimineral and antioxidants for adolescent girls, pregnant and lactating women, women going through menopause and for male and female reproductive health, it said.
The above molecules previously commercialised by Wanbury have a market size of Rs 3,100 crore in India with sales value of Rs 59.6 crore.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
